Transient Ischemic Attack: Clinical Trials

9 trials for Transient Ischemic Attack, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed. 9 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 39Completed 9
Phase 22Completed 2

Follow Transient Ischemic Attack: new trials by email Literature Review of Transient Ischemic Attack trials Research Report on Transient Ischemic Attack

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke
Ticagrelor 90mg, Clopidogrel 75 mg - Ischemic Stroke, Transient Ischemic Attack
Phase 3CompletedMazandaran University of Medical Sciences902021-08-082023-10-19
Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II
Ticagrelor and Aspirin, Clopidogrel and Aspirin - Stroke, Transient Ischemic Attack
Phase 3CompletedBeijing Tiantan Hospital64122019-09-232021-12-02
Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation
Apixaban, Warfarin - Transient Ischemic Attack, Stroke
Phase 3CompletedUniversity of South Florida912015-04-012021-11-30
Clopidogrel in High-risk Patients With Acute Non-disabling Cerebrovascular Events
Clopidogrel, Placebo of clopidogrel and Asprin - Stroke, Transient Ischemic Attack
Phase 3CompletedBeijing Tiantan Hospital51002009-12-012020-07-15
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
CPAP Therapy for Newly Diagnosed Obstructive Sleep Apnea (OSA) - Obstructive Sleep Apnea, Stroke
Phase 2 / Phase 3CompletedVA Office of Research and Development2252008-12-232017-06-14
Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER)
Aspirin, Clopidogrel, Simvastatin - Transient Ischemic Attack, Stroke
Phase 2 / Phase 3CompletedUniversity of Calgary5002003-05-012008-04-08
Aortic Arch Related Cerebral Hazard Trial (ARCH)
Warfarin, Clopidogrel-aspirin - Brain Infarction, Transient Ischemic Attack
Phase 3CompletedAssistance Publique - Hôpitaux de Paris3502002-02-012012-07-10
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™
EndoTex™ NexStent™, Filter Wire EZ™ - Transient Ischemic Attack, Thromboembolic Stroke
Phase 3CompletedBoston Scientific Corporation4882001-12-012008-01-24
EVA3S: Endarterectomy Versus Angioplasty in Patients With Severe Symptomatic Carotid Stenosis
Carotid angioplasty and stenting with cerebral protection - Transient Ischemic Attack, Carotid Stenosis
Phase 3CompletedAssistance Publique - Hôpitaux de Paris9002000-11-012011-05-02

Narrower conditions

Ischemic Attack, Transient (9)  ·  Stroke (6)  ·  Ischemic Stroke (2)  ·  Recurrence (2)  ·  Atherosclerosis (1)  ·  Atrial Fibrillation (1)  ·  Brain Infarction (1)  ·  Brain Ischemia (1)  ·  Carotid Stenosis (1)  ·  Embolism (1)  ·  Hypertension (1)  ·  Sleep Apnea Syndromes (1)  ·  Sleep Apnea, Obstructive (1)  ·  Thrombosis (1)

Broader conditions

Brain Diseases (9)  ·  Cardiovascular Diseases (9)  ·  Central Nervous System Diseases (9)  ·  Cerebrovascular Disorders (9)  ·  Nervous System Diseases (9)  ·  Vascular Diseases (9)  ·  Brain Ischemia (8)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Stroke (3)  ·  Disease Attributes (2)  ·  Embolism and Thrombosis (2)  ·  Apnea (1)  ·  Arrhythmias, Cardiac (1)  ·  Arterial Occlusive Diseases (1)

Interventions

Clopidogrel (4)  ·  Aspirin (3)  ·  Ticagrelor (2)  ·  Warfarin (2)  ·  Simvastatin (1)  ·  Stents (1)  ·  apixaban (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (2)  ·  Beijing Tiantan Hospital (2)  ·  Boston Scientific Corporation (1)  ·  Mazandaran University of Medical Sciences (1)  ·  University of Calgary (1)  ·  University of South Florida (1)  ·  VA Office of Research and Development (1)

Countries

United States (4)  ·  China (2)  ·  France (2)  ·  Argentina (1)  ·  Australia (1)  ·  Canada (1)  ·  Germany (1)  ·  Iran (1)

Top investigators

Alastair M Buchan (1)  ·  Athena Sharifi-Razavi (1)  ·  Cheryl Fontana, BSN (1)  ·  Dawn M. Bravata, MD (1)  ·  James Kennedy (1)  ·  L. Nelson Hopkins, MD (1)  ·  Michael Fradley, M.D. (1)  ·  Pierre Amarenco, Pr, MD, PhD (1)  ·  S.Claiborne NA Johnston, M.D, Ph.D (1)  ·  Subbarao Myla, MD (1)  ·  Yongjun NA Wang, M.D (1)  ·  Yongjun Wang, M.D (1)

Results publications

PMID 17050890, PMID 17931979, PMID 18774745, PMID 20542776, PMID 21885958, PMID 22334806, PMID 22968110, PMID 23237679, PMID 23803136, PMID 24458967, PMID 24699050, PMID 25082808, PMID 25957224, PMID 26012640, PMID 26330567, PMID 27001965, PMID 27328699, PMID 27613582, PMID 27738237, PMID 28289237, PMID 28455318, PMID 28959461, PMID 29051218, PMID 29507777, PMID 29773949, PMID 30089614, PMID 30355101, PMID 30355199, PMID 30355202, PMID 30621613, PMID 30742211, PMID 30972875, PMID 31127478, PMID 31378071, PMID 31620067, PMID 31726963, PMID 31822574, PMID 31941381, PMID 32355775, PMID 32606085, PMID 32958697, PMID 33093222, PMID 33493046, PMID 33626904, PMID 33952670, PMID 34708996, PMID 35224730, PMID 35256525, PMID 35656824, PMID 35695332